Barbara Bennett

Chembio lands $2.1M grant from Microsoft’s Allen

Medford-based Chembio Diagnostics has been awarded a $2.1 million grant from Microsoft co-founder Paul G. Allen to develop a speedier test for fevers, including Ebola and malaria. The one-year grant, from a $100 million Allen-funded Ebola eradication program, will cover development costs of a one-shot blood test for malaria, dengue, Ebola, Lassa, Marburg and chikungunya. Chembio chief executive John J. Sperzel said the six illnesses are characterized by a high-grade fever and can be fatal when…